GC
Guggenheim Capital Portfolio holdings
AUM
$12.3B
1-Year Return
20.77%
This Quarter Return
+2.75%
1 Year Return
+20.77%
3 Year Return
+81.12%
5 Year Return
+133.86%
10 Year Return
+300.64%
AUM
$12.1B
AUM Growth
-$2B
(-14%)
Cap. Flow
-$2.05B
Cap. Flow
% of AUM
-16.87%
Top 10 Holdings %
Top 10 Hldgs %
23.88%
Holding
1,963
New
109
Increased
646
Reduced
914
Closed
286
Top Buys
| 1 |
Palantir
PLTR
|
+$32.1M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$24.8M |
| 3 |
Applovin
APP
|
+$21.4M |
| 4 |
Strategy Inc Common Stock Class A
MSTR
|
+$11.9M |
| 5 |
Home Depot
HD
|
+$10.1M |
Top Sells
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$180M |
| 2 |
Broadcom
AVGO
|
+$103M |
| 3 |
Meta Platforms (Facebook)
META
|
+$68.3M |
| 4 |
Tesla
TSLA
|
+$47.5M |
| 5 |
NVIDIA
NVDA
|
+$34.5M |
Sector Composition
| 1 | Technology | 29.15% |
| 2 | Consumer Discretionary | 9.44% |
| 3 | Healthcare | 8.06% |
| 4 | Communication Services | 8.03% |
| 5 | Financials | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Perrigo
PRGO
$3.04B
| $1.2M | 0.01% |
46,844
+15,648
| +50% | +$402K |
|
|
TEI
827
Templeton Emerging Markets Income Fund
TEI
$297M
| $1.2M | 0.01% |
234,275
+38,949
| +20% | +$200K |
|
828
Legend Biotech
LEGN
$6.18B
| $1.2M | 0.01% |
36,924
+2,940
| +9% | +$95.7K |
|
829
Enbridge
ENB
$106B
| $1.2M | 0.01% |
28,270
+1,128
| +4% | +$47.9K |
|
830
Credicorp
BAP
$21B
| $1.2M | 0.01% |
6,536
+534
| +9% | +$97.9K |
|
831
American Financial Group
AFG
$11.4B
| $1.2M | 0.01% |
8,735
-651
| -7% | -$89.1K |
|
832
iShares JPMorgan EM High Yield Bond ETF
EMHY
$500M
| $1.19M | 0.01% |
31,454
-424
| -1% | -$16.1K |
|
833
Sabra Healthcare REIT
SBRA
$4.54B
| $1.19M | 0.01% |
68,941
-143,382
| -68% | -$2.48M |
|
834
National Health Investors
NHI
$3.71B
| $1.19M | 0.01% |
17,152
-895
| -5% | -$62K |
|
835
AutoNation
AN
$8.42B
| $1.18M | 0.01% |
6,967
-22,262
| -76% | -$3.78M |
|
836
Lattice Semiconductor
LSCC
$9.06B
| $1.18M | 0.01% |
20,833
-11,401
| -35% | -$646K |
|
837
Unilever
UL
$154B
| $1.16M | 0.01% |
20,536
+3,809
| +23% | +$216K |
|
838
Vodafone
VOD
$28B
| $1.16M | 0.01% |
136,957
+58,091
| +74% | +$493K |
|
839
ADMA Biologics
ADMA
$3.76B
| $1.16M | 0.01% |
67,778
+57,000
| +529% | +$978K |
|
840
Masimo
MASI
$7.92B
| $1.16M | 0.01% |
7,021
+2,674
| +62% | +$442K |
|
841
Turkcell
TKC
$4.79B
| $1.16M | 0.01% |
178,058
-33,254
| -16% | -$216K |
|
842
Carpenter Technology
CRS
$12.3B
| $1.16M | 0.01% |
6,817
+3,101
| +83% | +$526K |
|
843
ICICI Bank
IBN
$113B
| $1.16M | 0.01% |
38,722
+4,860
| +14% | +$145K |
|
844
Hillenbrand
HI
$1.75B
| $1.16M | 0.01% |
37,535
+8,611
| +30% | +$265K |
|
845
W.P. Carey
WPC
$14.8B
| $1.15M | 0.01% |
21,124
-109,253
| -84% | -$5.95M |
|
846
VanEck Preferred Securities ex Financials ETF
PFXF
$1.91B
| $1.15M | 0.01% |
66,667
+5,419
| +9% | +$93.5K |
|
847
First Merchants
FRME
$2.32B
| $1.15M | 0.01% |
28,735
-196,606
| -87% | -$7.84M |
|
|
BPMC
848
DELISTED
Blueprint Medicines
BPMC
| $1.15M | 0.01% |
13,139
-3,725
| -22% | -$325K |
|
849
DNP Select Income Fund
DNP
$3.72B
| $1.14M | 0.01% |
129,761
+46,173
| +55% | +$407K |
|
850
Paycom
PAYC
$12.4B
| $1.14M | 0.01% |
5,577
+1,808
| +48% | +$371K |
|